Chuang Yi Biotech co., ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 291.84 million compared to TWD 268.52 million a year ago. Revenue was TWD 276.69 million compared to TWD 260.69 million a year ago.

Net income was TWD 4.25 million compared to net loss of TWD 31.52 million a year ago. Basic earnings per share from continuing operations was TWD 0.2912 compared to basic loss per share from continuing operations of TWD 2.0829 a year ago. Diluted earnings per share from continuing operations was TWD 0.2912 compared to diluted loss per share from continuing operations of TWD 2.0829 a year ago.